Attached files

file filename
10-K - 10-K - WaferGen Bio-systems, Inc.wgbs-12312015x10k.htm
EX-10.3 - EXHIBIT 10.3 - WaferGen Bio-systems, Inc.ex_10-3xformofiso.htm
EX-10.2 - EXHIBIT 10.2 - WaferGen Bio-systems, Inc.ex_10-2xformofrsa.htm
EX-21.1 - EXHIBIT 21.1 - WaferGen Bio-systems, Inc.ex_21-1xsubsidiaries.htm
EX-31.2 - EXHIBIT 31.2 - WaferGen Bio-systems, Inc.wgbs-12312015xex_31x2.htm
EX-32.2 - EXHIBIT 32.2 - WaferGen Bio-systems, Inc.wgbs-12312015xex_32x2.htm
EX-31.1 - EXHIBIT 31.1 - WaferGen Bio-systems, Inc.wgbs-12312015xex_31x1.htm
EX-32.1 - EXHIBIT 32.1 - WaferGen Bio-systems, Inc.wgbs-12312015xex_32x1.htm
EXHIBIT 23.1



CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We consent to the incorporation by reference in the Registration Statements (Nos. 333-152597, 333-164558, 333-170029, 333-180287, 333-196534 and 333-200684) on Form S-8 and in the Registration Statements (Nos. 333-191645, 333-192003, 333-196328 and 333-201729) on Form S-3 of WaferGen Bio-systems, Inc. and subsidiaries (collectively, the “Company”) of our report dated March 25, 2016, relating to our audit of the consolidated financial statements, which appears in this Annual Report on Form 10-K of the Company for the year ended December 31, 2015.

/s/ SingerLewak LLP

San Jose, California
March 25, 2016